Loading...
HeartBeam, Inc.
BEAT•NASDAQ
Healthcare
Medical - Healthcare Information Services
$1.27
$-0.01(-0.78%)
HeartBeam, Inc. (BEAT) Financial Performance & Income Statement Overview
Review HeartBeam, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-29.86%
↓ 29.86%
Net Income Growth
-32.85%
↓ 32.85%
Operating Cash Flow Growth
-19.66%
↓ 19.66%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-358.33%
↓ 358.33%
ROIC
-273.70%
↓ 273.70%
HeartBeam, Inc. (BEAT) Income Statement & Financial Overview
Review HeartBeam, Inc.'s (BEAT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $2.89M | $2.89M | $2.84M | $2.43M |
| SG&A Expenses | $2.06M | $2.18M | $2.25M | $2.36M |
| Operating Expenses | $4.94M | $5.07M | $5.09M | $4.78M |
| Total Costs & Expenses | $4.94M | $5.07M | $5.09M | $4.78M |
| Interest Income | $38000.00 | $96000.00 | $134000.00 | $178000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $5.09M | $4.78M |
| EBITDA | -$4.94M | -$5.07M | -$5.09M | $0.00 |
| EBITDA Ratio | ||||
| Operating Income | -$4.94M | -$5.07M | -$5.09M | -$4.78M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $37000.00 | $90000.00 | $134000.00 | $178000.00 |
| Income Before Tax | -$4.91M | -$4.98M | -$4.96M | -$4.61M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | -$5.09M | -$4.78M |
| Net Income | -$4.91M | -$4.98M | -$4.96M | -$4.61M |
| Net Income Ratio | ||||
| EPS | -$0.18 | -$0.19 | -$0.19 | -$0.17 |
| Diluted EPS | -$0.18 | -$0.19 | -$0.19 | -$0.17 |
| Weighted Avg Shares Outstanding | $26.65M | $26.75M | $26.57M | $26.51M |
| Weighted Avg Shares Outstanding (Diluted) | $26.65M | $26.75M | $26.57M | $26.51M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan